Tag: Monsanto
Jury hands down $2.25 billion verdict to Bayer in Roundup weed...
John McKivison sued Bayer because he believes he developed cancer after using Roundup on his property for two decades,
A poisoned legacy: challenging the EPA’s reluctance to ban glyphosate amidst...
Unveiling the controversy: a deep dive into the legal, scientific, and humanitarian debate over glyphosate's future
Glyphosate sales fall as Bayer takes a €2.5 billion hit
A “significant further decline” of glyphosate sales could push Bayer towards a breakup of its agriculture business.
Glyphosate found in more than 80% of U.S. urine samples
Glyphosate was listed as a probable human carcinogen by the World Health Organization’s International Agency for Research on Cancer in 2015.
Bayer appeal to dismiss Roundup weedkiller lawsuits rejected by U.S. Supreme...
Bayer said it plans to replace glyphosate-based weed-killing ingredients in products for non-professionals in the U.S. with alternative active ingredients in order to “manage litigation risk in the U.S.,” but not due to concerns about safety.
The rest of the story—Monsanto owner Bayer struggles to shed Roundup...
Monsanto owner, Bayer AG, is contemplating pulling the popular herbicide from the residential market as it struggles to cement a strategy to limit ongoing litigation.
Bayer considers putting an end to US glyphosate sales
“Removing glyphosate from residential use would be a step in the right direction.”
Roundup verdict of $25M upheld in US appeals court
“It’s a slam dunk for plaintiffs. This proves these claims are viable in the tort system.”
Bayer and US officials pressure Mexico to overturn glyphosate ban
“Will they continue the pattern of doing the bidding of global biotech/seed firms like Monsanto? Or, will the USTR respect other countries’ rights to protect the environment and indigenous crops?”
Appeals court upholds groundskeeper’s Roundup cancer trial win over Monsanto
The court said that Monsanto’s argument that scientific findings about glyphosate’s links to cancer constituted a “minority view” was not supported.